| Breast Cancer and Posttraumatic Growth | FİGEN ŞENGÜN İNAN,Besti ÜSTÜN | 75–78 |
| Guideline for Antimicrobial Prophylaxis in Breast Surgery | Sema BAĞHAKİ,Gürsel Remzi SOYBİR,Atilla SORAN | 79–82 |
| Comparison of Different Techniques in Breast Cancer Radiotherapy Planning | F. Gülşen KARA,Ayfer HAYDAROĞLU,HAKAN EREN,Gül KİTAPÇIOĞLU | 83–87 |
| Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer | Altan ÖZDEMİR,Burhan MAYIR,Kenan DEMİRBAKAN,Nezihi OYGÜR | 88–91 |
| Frequency of Early-Stage Lymphedema and Risk Factors in Postoperative Patients with Breast Cancer | Aykut SOYDER,ENGİN TAŞTABAN,Serdar ÖZBAŞ,Şükrü BOYLU,HEDEF ÖZGÜN | 92–97 |
| Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients) | VAHİT ÖZMEN | 98–105 |
| Comparison of Chest Wall and Lymphatic Radiotherapy Techniques in Patients with Left Breast Carcinoma | MELİS GÜLTEKİN,Mehmet KARABUĞA,Ferah YILDIZ,Gökhan ÖZYİĞİT,Mustafa CENGİZ,ABDULLAH FARUK ZORLU,Fadıl AKYOL,Murat GÜRKAYNAK | 106–110 |
| Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive Breast Cancer | NACİYE SİNEM GEZER,Özge ORBAY,Pınar BALCI,Merih Güray DURAK,HATİCE MİRAÇ BİNNAZ DEMİRKAN,Serdar SAYDAM | 111–118 |
| A Rare Breast Tumor Confused with Ductal Carcinoma in Situ, Primary Solid Neuroendocrine Carcinoma | Ömer ALICI,Serap AYDOĞDU KORKMAZ | 119–121 |
| Virginal Breast Hypertrophy and Symptomatic Treatment: A Case Report | Ebru MENEKŞE,Safa ÖNEL,Faruk KARATEKE,KORAY DAŞ,İLHAN BALİ,Hilmi BOZKURT,Selim SÖZEN,Mehmet ÖZDOĞAN | 122–124 |
| Primary Neuroendocrine Carcinoma of the Breast: A Report of Three Cases | Faruk AKSOY,Ebubekir GÜNDEŞ,CELALETTİN VATANSEV,MURAT ÇAKIR,Hatice TOY,Ganime Dilek EMLİK | 125–128 |